Clonidine Hydrochloride

盐酸可乐定

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameClonidine Hydrochloride
Drug Alias Name[2-(2,6-二氯苯基)亚氨基]咪唑烷盐酸盐CatapresCloniBIDClonicelDuraclon +[20] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAlpha-2c adrenergic receptorAlpha-2a adrenergic receptorAlpha-2b adrenergic receptor +[4] 
Therapy Area/IndicationsStress Disorders, Post-TraumaticAutism Spectrum DisorderAttention Deficit Disorder with Hyperactivity +[28] 
Global Approved IndicationsHypertensionMigraine DisordersVascular Headaches
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryJapan
Original Approved Date1969/05/15
Country/TerritoryCanadaUnited StatesPuerto Rico +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSabal Therapeutics LLCWake Forest University Health SciencesMylan Institutional Inc +[5] 
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgFederal University Of Sao PauloMonopar Therapeutics Inc +[21] 
Active IndicationsStress Disorders, Post-TraumaticSleepCancer Pain +[7] 
Inactive IndicationsAutism Spectrum DisorderAttention Deficit Disorder with HyperactivityHeroin Dependence +[21] 

Other Information

ATC CodeC02AC01N02CX02S01EA04
Related LinksWikipediaDrugBankKEGG